Denise oversees a group of US and European journalists covering biopharma regulatory and policy news and trends, primarily published in Pink Sheet. She also teams up with colleagues on strategic content initiatives affecting multiple Citeline publications as well as recruiting, training, website enhancements and collaborations with sales and marketing, and is involved in regulatory new product development. She has had a colorful history as a reporter and senior editor on predecessor publications to Citeline’s current offerings, including Pink Sheet, Blue Sheet (NIH and public health programs), Beige Sheet (medical technology reimbursement) and Medicare Drug Focus. Her areas of particular expertise include Capitol Hill and health care reimbursement. Outside of the office, her interests include culinary history and she is a long-time literacy volunteer.
Latest from Denise Peterson
A visual perspective on key regulatory topics in 2023, from clinical trial diversity to product approval trends and Medicare drug price negotiation.
From US drug pricing to Japan’s Sakigake expedited pathway, important regulatory developments and trends are easier to understand and track with Pink Sheet graphics.
Kenny, a mainstay of our publications for three decades, has passed away in London.
Kenny, a mainstay of our publications for three decades, has passed away in London.
Kenny, a mainstay of our publications for three decades, has passed away in London.
Coverage of clinical trial policy included commentary on rapid growth of the PD-1 pipeline by both US and China regulators; case studies and discussion of trial strategies including RWE, pediatric studies and decentralized trials; and US FDA commissioner-nominee Robert Califf’s R&D expertise.